By: Kevin Kobielski, President of Navion Pharmacy benefit managers often offer appealing guarantees—rebates, discounts, and price protections among some of them. But […]
By Beckie Fenrick, PharmD, MBA and Jason Peterson, RPh Q4 2025 brings meaningful FDA activity across high-cost therapeutic areas, along
By: Kevin Kobielski, President of Navion As specialty drug costs continue to rise, alternative funding programs like Manufacturer Assistance Programs
By Jason Peterson, RPh and Beckie Fenrick, PharmD, MBA Infused and injectable therapies play a critical role in treating complex conditions, but they also represent some of
By: Kevin Kobielski, President of Navion At first glance, many pharmacy benefit proposals can feel impressive—thick with rebate guarantees, discount percentages, and
By Beckie Fenrick, PharmD, MBA and Jason Peterson, RPh As pharmacy costs climb and personalization reshapes every corner of healthcare,
By: Kevin Kobielski, President of Navion In the world of pharmacy benefits, “transparency” has become a golden word—implying clarity, fairness,
Already a Navion Partner?
Access co-branded resources and strategy tools via our Partner Portal.
Join our Newsletter
Stay up to date on features and releases.
© 2026 Navion. All rights reserved.
